tiprankstipranks
Zimmer Biomet Holdings (DE:ZIM)
FRANKFURT:ZIM
Germany Market
ZIM
Zimmer Biomet Holdings
RESEARCH TOOLSreports

Zimmer Biomet Holdings (ZIM) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

ZIM Analyst Ratings

Moderate Buy
17Ratings
Moderate Buy
5 Buy
12 Hold
0 Sell
Based on 17 analysts giving stock ratings to
Zimmer
Biomet Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZIM Stock 12 Month Forecast

Average Price Target

€89.70
▲(10.20% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is €89.70 with a high forecast of €104.15 and a low forecast of €72.03. The average price target represents a 10.20% change from the last price of €81.40.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"66":"€66","105":"€105","75.75":"€75.8","85.5":"€85.5","95.25":"€95.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":104.1456024,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€104.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":89.70159920999998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€89.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":72.03404166,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€72.03</span>\n  </div></div>","useHTML":true}}],"tickPositions":[66,75.75,85.5,95.25,105],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.06,81.91273864615385,83.7654772923077,85.61821593846155,87.47095458461538,89.32369323076924,91.17643187692308,93.02917052307693,94.88190916923077,96.73464781538462,98.58738646153846,100.44012510769231,102.29286375384615,{"y":104.1456024,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.06,80.8016614776923,81.54332295538461,82.28498443307691,83.02664591076923,83.76830738846154,84.50996886615384,85.25163034384614,85.99329182153845,86.73495329923075,87.47661477692307,88.21827625461538,88.95993773230768,{"y":89.70159920999998,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.06,79.44261858923078,78.82523717846153,78.20785576769231,77.59047435692308,76.97309294615384,76.35571153538461,75.73833012461539,75.12094871384616,74.50356730307692,73.8861858923077,73.26880448153847,72.65142307076923,{"y":72.03404166,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":78.92,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.033,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.505,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.441,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.605,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.962,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.964,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.566,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.972,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.246,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.16,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.06,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€104.15Average Price Target€89.70Lowest Price Target€72.03
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on DE:ZIM
Richard Newitter
Truist Financial
Truist Financial
€92
Hold
13.02%
Upside
Reiterated
08/07/26
Zimmer Biomet price target raised to $106 from $92 at TruistZimmer Biomet price target raised to $106 from $92 at Truist
William Blair Analyst forecast on DE:ZIM
Steven Lichtman
William Blair
William Blair
―
Hold
―
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Enliven Therapeutics (NASDAQ: ELVN) and Encompass Health (NYSE: EHC)
Robert W. Baird Analyst forecast on DE:ZIM
Jeff Johnson
Robert W. Baird
Robert W. Baird
€79.84→€90.26
Hold
10.88%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $104 from $92 at BairdZimmer Biomet price target raised to $104 from $92 at Baird
Deutsche Bank Analyst forecast on DE:ZIM
Pito Chickering
Deutsche Bank
Deutsche Bank
€76.37→€85.05
Hold
4.49%
Upside
Reiterated
08/06/26
Deutsche Bank Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
Wells Fargo Analyst forecast on DE:ZIM
Larry Biegelsen
Wells Fargo
Wells Fargo
€78.11→€89.39
Hold
9.82%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Cytek Biosciences (NASDAQ: CTKB) and Sight Sciences (NASDAQ: SGHT)
Citi Analyst forecast on DE:ZIM
Joanne Wuensch
Citi
Citi
€80.71→€85.92
Hold
5.55%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $99 from $93 at CitiZimmer Biomet price target raised to $99 from $93 at Citi
BMO Capital Analyst forecast on DE:ZIM
Vik Chopra
BMO Capital
BMO Capital
€82.45→€83.32
Hold
2.35%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $96 from $95 at BMO CapitalZimmer Biomet price target raised to $96 from $95 at BMO Capital
Stifel Nicolaus Analyst forecast on DE:ZIM
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
€91.13→€95.47
Buy
17.28%
Upside
Assigned
08/06/26
Zimmer Biomet Holdings (ZBH) Receives a Buy from Stifel Nicolaus
Bernstein Analyst forecast on DE:ZIM
Lee Hambright
Bernstein
Bernstein
€78.98→€80.71
Hold
-0.84%
Downside
Reiterated
08/06/26
Zimmer Biomet Holdings (ZBH) Gets a Hold from Bernstein
UBS Analyst forecast on DE:ZIM
Patrick Wood
UBS
UBS
€99.81→€104.15
Buy
27.94%
Upside
Reiterated
08/06/26
UBS Remains a Buy on Zimmer Biomet Holdings (ZBH)
Needham Analyst forecast on DE:ZIM
Michael Matson
Needham
Needham
―
Hold
―
Reiterated
08/05/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN), Zimmer Biomet Holdings (NYSE: ZBH) and Recursion Pharmaceuticals (NASDAQ: RXRX)
TD Cowen Analyst forecast on DE:ZIM
Mathew Blackman
TD Cowen
TD Cowen
€94.6→€99.81
Buy
22.61%
Upside
Reiterated
08/05/26
Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen
Canaccord Genuity Analyst forecast on DE:ZIM
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
€72.03
Hold
-11.51%
Downside
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biodesix (NASDAQ: BDSX), Incyte (NASDAQ: INCY) and Zimmer Biomet Holdings (NYSE: ZBH)
RBC Capital Analyst forecast on DE:ZIM
Kendall Au
RBC Capital
RBC Capital
€87.66→€95.47
Buy
17.28%
Upside
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Mirum Pharmaceuticals (NASDAQ: MIRM), Zimmer Biomet Holdings (NYSE: ZBH) and Editas Medicine (NASDAQ: EDIT)
BTIG Analyst forecast on DE:ZIM
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
07/23/26
Zimmer Biomet: Solid Orthopedics Franchise and Early-Stage Digital Investments Support Neutral Risk-Reward, Justifying Hold Rating
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on DE:ZIM
Richard Newitter
Truist Financial
Truist Financial
€92
Hold
13.02%
Upside
Reiterated
08/07/26
Zimmer Biomet price target raised to $106 from $92 at TruistZimmer Biomet price target raised to $106 from $92 at Truist
William Blair Analyst forecast on DE:ZIM
Steven Lichtman
William Blair
William Blair
―
Hold
―
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Enliven Therapeutics (NASDAQ: ELVN) and Encompass Health (NYSE: EHC)
Robert W. Baird Analyst forecast on DE:ZIM
Jeff Johnson
Robert W. Baird
Robert W. Baird
€79.84→€90.26
Hold
10.88%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $104 from $92 at BairdZimmer Biomet price target raised to $104 from $92 at Baird
Deutsche Bank Analyst forecast on DE:ZIM
Pito Chickering
Deutsche Bank
Deutsche Bank
€76.37→€85.05
Hold
4.49%
Upside
Reiterated
08/06/26
Deutsche Bank Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
Wells Fargo Analyst forecast on DE:ZIM
Larry Biegelsen
Wells Fargo
Wells Fargo
€78.11→€89.39
Hold
9.82%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Cytek Biosciences (NASDAQ: CTKB) and Sight Sciences (NASDAQ: SGHT)
Citi Analyst forecast on DE:ZIM
Joanne Wuensch
Citi
Citi
€80.71→€85.92
Hold
5.55%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $99 from $93 at CitiZimmer Biomet price target raised to $99 from $93 at Citi
BMO Capital Analyst forecast on DE:ZIM
Vik Chopra
BMO Capital
BMO Capital
€82.45→€83.32
Hold
2.35%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $96 from $95 at BMO CapitalZimmer Biomet price target raised to $96 from $95 at BMO Capital
Stifel Nicolaus Analyst forecast on DE:ZIM
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
€91.13→€95.47
Buy
17.28%
Upside
Assigned
08/06/26
Zimmer Biomet Holdings (ZBH) Receives a Buy from Stifel Nicolaus
Bernstein Analyst forecast on DE:ZIM
Lee Hambright
Bernstein
Bernstein
€78.98→€80.71
Hold
-0.84%
Downside
Reiterated
08/06/26
Zimmer Biomet Holdings (ZBH) Gets a Hold from Bernstein
UBS Analyst forecast on DE:ZIM
Patrick Wood
UBS
UBS
€99.81→€104.15
Buy
27.94%
Upside
Reiterated
08/06/26
UBS Remains a Buy on Zimmer Biomet Holdings (ZBH)
Needham Analyst forecast on DE:ZIM
Michael Matson
Needham
Needham
―
Hold
―
Reiterated
08/05/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Geron (NASDAQ: GERN), Zimmer Biomet Holdings (NYSE: ZBH) and Recursion Pharmaceuticals (NASDAQ: RXRX)
TD Cowen Analyst forecast on DE:ZIM
Mathew Blackman
TD Cowen
TD Cowen
€94.6→€99.81
Buy
22.61%
Upside
Reiterated
08/05/26
Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen
Canaccord Genuity Analyst forecast on DE:ZIM
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
€72.03
Hold
-11.51%
Downside
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biodesix (NASDAQ: BDSX), Incyte (NASDAQ: INCY) and Zimmer Biomet Holdings (NYSE: ZBH)
RBC Capital Analyst forecast on DE:ZIM
Kendall Au
RBC Capital
RBC Capital
€87.66→€95.47
Buy
17.28%
Upside
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Mirum Pharmaceuticals (NASDAQ: MIRM), Zimmer Biomet Holdings (NYSE: ZBH) and Editas Medicine (NASDAQ: EDIT)
BTIG Analyst forecast on DE:ZIM
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
07/23/26
Zimmer Biomet: Solid Orthopedics Franchise and Early-Stage Digital Investments Support Neutral Risk-Reward, Justifying Hold Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
TNYATenaya Therapeutics
JBIOJade Biosciences
GHRSGH Research
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zimmer Biomet Holdings

3 Months
Jason WittesRoth MKM
Success Rate
7/11 ratings generated profit
64%
Average Return
-0.03%
Copying Jason Wittes's trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of -0.03% per trade.
1 Year
Jason WittesRoth MKM
Success Rate
6/11 ratings generated profit
55%
Average Return
+0.42%
Copying Jason Wittes's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +0.42% per trade.
2 Years
Jason WittesRoth MKM
Success Rate
7/11 ratings generated profit
64%
Average Return
+0.89%
Copying Jason Wittes's trades and holding each position for 2 Years would result in 63.64% of your transactions generating a profit, with an average return of +0.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZIM Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
11
7
6
5
9
Hold
21
16
17
10
18
Sell
4
1
1
0
0
Strong Sell
0
0
0
0
0
total
36
24
24
15
27
In the current month, ZIM has received 9 Buy Ratings, 18 Hold Ratings, and 0 Sell Ratings. ZIM average Analyst price target in the past 3 months is 89.70.
Each month's total comprises the sum of three months' worth of ratings.

ZIM Financial Forecast

ZIM Earnings Forecast

Next quarter’s earnings estimate for ZIM is €1.63 with a range of €1.61 to €1.65. The previous quarter’s EPS was €1.79. ZIM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.38% of the time in the same period. In the last calendar year ZIM has Performed in-line its overall industry.
Next quarter’s earnings estimate for ZIM is €1.63 with a range of €1.61 to €1.65. The previous quarter’s EPS was €1.79. ZIM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.38% of the time in the same period. In the last calendar year ZIM has Performed in-line its overall industry.

ZIM Sales Forecast

Next quarter’s sales forecast for ZIM is €1.77B with a range of €1.76B to €1.78B. The previous quarter’s sales results were €1.88B. ZIM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 30.71% of the time in the same period. In the last calendar year ZIM has Performed in-line its overall industry.
Next quarter’s sales forecast for ZIM is €1.77B with a range of €1.76B to €1.78B. The previous quarter’s sales results were €1.88B. ZIM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 30.71% of the time in the same period. In the last calendar year ZIM has Performed in-line its overall industry.

ZIM Stock Forecast FAQ

What is DE:ZIM’s average 12-month price target, according to analysts?
Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is 89.70.
    What is DE:ZIM’s upside potential, based on the analysts’ average price target?
    Zimmer Biomet Holdings has 10.20% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Zimmer Biomet Holdings a Buy, Sell or Hold?
          Zimmer Biomet Holdings has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 12 hold ratings and 0 sell ratings.
            What is Zimmer Biomet Holdings’s share price target?
            The average share price target for Zimmer Biomet Holdings is 89.70. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €104.15 ,and the lowest forecast is €72.03. The average share price target represents 10.20% Increase from the current price of €81.4.
              What do analysts say about Zimmer Biomet Holdings?
              Zimmer Biomet Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of Zimmer Biomet Holdings?
                To buy shares of DE:ZIM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.